ArticleThe Journal of antibiotics2026
Thiofrenomycins, new kalafungin-type pyranonaphthoquinone skeleton with sulfide linkage from Streptomyces sp. MM863L-181F9.
Article in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neisseria gonorrhoeae is the bacterium that causes gonorrhea, and multidrug resistance is becoming progressively more severe in many countries. Therefore, limited drugs are available for treatment. It is predicted that further drug resistance will be acquired, making treatment still more difficult, so there is an urgent need to develop new drugs. We discovered three compounds with a new kalafungin-type pyranonaphthoquinone skeleton, thiofrenomycins A-C, that exhibit strong antibacterial activity against N. gonorrhoeae in a culture solution of Streptomyces sp. MM863L-181F9 derived from fallen leaves. The absolute stereochemistry of these compounds was determined using X-ray crystal structure analysis. These substances exhibit minimal inhibitory concentrations of 0.125-16 µg/mL against N. gonorrhoeae.
Indexed as
Identifiers
41272307What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.